The use of in vivo CAMPATH-1H is associated with persistent defects in humoral immunity after reduced intensity conditioned sibling allogeneic stem cell transplantation despite enhanced reconstitution of marrow CD20+B-cells.

S. Tauro, K. Piper, M. Cobbold, M. T. Drayson, R. Chakraverty, P. Mahendra, C. F. Craddock, P. A. Moss

Research output: Contribution to journalArticle

Cite this